February 20, 2026

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 85% Potential Upside Sparks Investor Interest

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is currently making waves in the biotech sector with its promising pipeline of cancer therapies. With a..

Abivax SA (ABVX) Investor Outlook: Assessing the 17.4% Upside Potential and Strategic Position in the Biotech Sector

Abivax SA (ABVX), a prominent player in the biotechnology sector, has recently captured the attention of investors, particularly with a remarkable potential upside of 17.4%. As..

COMPASS Pathways (CMPS) Investor Outlook: Exploring a 135% Potential Upside in Mental Health Revolution

Investors keen on exploring the frontier of mental health treatment may find COMPASS Pathways Plc (NASDAQ: CMPS) an intriguing prospect. As a biotechnology company at the..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring the 18.78% Potential Upside for Investors

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Based in Boca Raton, Florida,..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 72.62% Potential Upside with Strong Buy Ratings

For investors keen on the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents an intriguing opportunity, particularly with its potential upside of 72.62%, as indicated by the..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a 22.84% Potential Upside Amidst Healthcare Challenges

Emergent BioSolutions Inc. (NYSE: EBS) is carving out a niche in the healthcare sector as a provider of solutions for public health threats, ranging from pandemics..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a 63.98% Potential Upside in Biotech Innovation

MBX Biosciences, Inc. (MBX), a burgeoning force in the biotechnology sector, is making waves with its innovative approach to addressing endocrine and metabolic disorders. While currently..

Standard BioTools Inc. (LAB) Stock Analysis: Healthcare Innovator Shows 34.78% Potential Upside

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, offers a compelling opportunity for investors seeking growth in the biotechnological..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Promising 71.70% Potential Upside in Biotech Innovation

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is currently capturing the attention of investors with its impressive 71.70% potential upside. As a clinical-stage biopharmaceutical company, Oruka is at..

Arvinas, Inc. (ARVN) Stock Analysis: Unlocking Potential in Biotechnology with an 8.52% Upside

Arvinas, Inc. (ARVN), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to tackling disease-causing proteins. The company,..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 113% Potential Upside in Healthcare Innovation

In the dynamic landscape of regenerative medicine, Organogenesis Holdings Inc. (NASDAQ: ORGO) is carving a niche with its innovative portfolio targeting advanced wound care and surgical..

PureTech Health plc (PRTC) Stock Analysis: A Beacon of Innovation in the Biotechnology Sector

PureTech Health plc (PRTC), a player in the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to cutting-edge healthcare innovations. With a market cap..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 50% Upside Potential

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, specializes in manufacturing plasma-derived protein therapeutics. Headquartered in Rehovot, Israel, Kamada’s diverse product portfolio addresses..

Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a 118.75% Potential Upside Amidst Healthcare Innovation

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering company in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its..

Rapport Therapeutics, Inc. (RAPP) Investor Outlook: Analyzing a 70.80% Potential Upside

For investors with a keen eye on the biotechnology sector, Rapport Therapeutics, Inc. (NASDAQ: RAPP) presents a compelling opportunity, particularly with a projected potential upside of..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Biotech with 57% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology firm, is capturing the attention of investors with its notable potential upside of 57.33%, according to analyst ratings...

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator’s 9.29% Upside Captures Investor Attention

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to cancer treatment. With a market capitalization..

AnaptysBio, Inc. (ANAB) Investor Outlook: Analyzing a 22.46% Potential Upside with Strong Buy Ratings

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company headquartered in San Diego, California, is capturing investor attention with an enticing 22.46% potential upside, as indicated by..

Bioventus Inc. (BVS) Investor Outlook: A 69% Potential Upside and Strong Analyst Ratings

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, specifically within the medical devices industry, has caught the eye of investors with a robust..

Kura Oncology, Inc. (KURA): Investor Outlook with a Promising 278% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is gaining significant attention from investors with its potential for substantial upside...

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds